Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
- PMID: 27533794
- DOI: 10.1002/cncr.30260
Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
Erratum in
-
Erratum.Cancer. 2017 Feb 15;123(4):710. doi: 10.1002/cncr.30492. Epub 2016 Dec 16. Cancer. 2017. PMID: 28165620 No abstract available.
Comment on
-
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.Cancer. 2016 Nov 15;122(21):3344-3353. doi: 10.1002/cncr.30258. Epub 2016 Aug 17. Cancer. 2016. PMID: 27533448 Free PMC article.
-
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.Cancer. 2016 Nov 15;122(21):3354-3362. doi: 10.1002/cncr.30259. Epub 2016 Aug 17. Cancer. 2016. PMID: 27533633 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
